1. Xing, Huiwu, Jiang, Xiangqi, Yang, Chenyu, Hu, Jiqiang, Zhang, Mingman. 2023. High expression of RPL27A predicts poor prognosis in patients with hepatocellular carcinoma. In World journal of surgical oncology, 21, 209. doi:10.1186/s12957-023-03102-w. https://pubmed.ncbi.nlm.nih.gov/37474947/
2. Yu, Xin, Xu, Chao, Zou, Yiping, Xie, Yongjie, Wu, Chao. 2024. A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma. In American journal of cancer research, 14, 253-273. doi:. https://pubmed.ncbi.nlm.nih.gov/38323276/
3. Alkhatabi, Heba A, McLornan, Donal P, Kulasekararaj, Austin G, Gaken, Joop, Mufti, Ghulam J. . RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis. In Oncotarget, 7, 47875-47890. doi:10.18632/oncotarget.10293. https://pubmed.ncbi.nlm.nih.gov/27374104/
4. Zhang, Zhengxiang, Liu, Zhiping, Zhao, WeiDong, Zhao, Xiaohan, Tao, Yunxiang. . tRF-19-W4PU732S promotes breast cancer cell malignant activity by targeting inhibition of RPL27A (ribosomal protein-L27A). In Bioengineered, 13, 2087-2098. doi:10.1080/21655979.2021.2023796. https://pubmed.ncbi.nlm.nih.gov/35030975/
5. Szakonyi, Dóra, Byrne, Mary E. 2011. Involvement of ribosomal protein RPL27a in meristem activity and organ development. In Plant signaling & behavior, 6, 712-4. doi:. https://pubmed.ncbi.nlm.nih.gov/21448008/